Clinical Trial Update: An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

An open-label, follow-on Phase 2 trial evaluating the long-term safety and efficacy of oral SPM 927 in subjects with postherpetic neuralgia, which has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• SPM 927 (SPM 927)

Snippet

Sponsor: UCB Pharma | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED